SKI Market

A+| A| A-|

Indian Indices

Sensex

79,273.33 753.03
( 0.96%)

Global Indices

Nasdaq

49,166.17 -297.40
(-0.60%)

Dow Jones

7,084.21 -45.93
(-0.64%)

Hang Seng

59,361.39 536.50
(0.91%)

Nikkei 225

10,503.87 -105.21
(-0.99%)

Forex

USD-INR

92.58 -0.61
(-0.65%)

EUR-INR

108.87 -0.98
(-0.89%)

GBP-INR

125.07 -1.17
(-0.93%)

JPY-INR

0.58 0.00
(-0.45%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Ajanta Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

532331

INE031B01049

330.3875196

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AJANTPHARM

37.04

34930.75

EPS(TTM)

Face Value()

Div & Yield %

75.48

Particulars(INCOME)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)
Sales Turnover	4322.04	3971.12	3411.27	3140.64	2718.59	2196.42
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	4322.04	3971.12	3411.27	3140.64	2718.59	2196.42
Other Income	119.87	116.48	132.75	139.73	103.57	184.20
Stock Adjustments	18.58	22.17	21.99	56.60	74.60	-9.02
Total Income	4460.49	4109.77	3566.01	3336.97	2896.76	2371.60
EXPENDITURE :
Raw Materials	1030.60	1101.59	1027.40	889.16	804.68	654.95
Power & Fuel Cost	70.22	66.44	65.53	54.09	43.42	38.56
Employee Cost	1010.90	834.16	720.41	585.87	498.11	437.82
Other Manufacturing Expenses	198.94	168.11	185.50	169.95	119.25	124.80
Selling & Administrative Expenses	695.46	587.02	602.95	512.46	324.31	308.60
Miscellaneous Expenses	129.78	116.54	132.19	94.82	86.51	93.81
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	3135.90	2873.86	2733.98	2306.35	1876.28	1658.54
Operating Profit	1324.59	1235.91	832.03	1030.62	1020.48	713.06
Interest	4.60	6.80	5.23	9.12	6.90	9.10
Gross Profit	1319.99	1229.11	826.80	1021.50	1013.58	703.96
Depreciation	139.93	132.16	126.95	120.96	111.49	91.29
Profit Before Tax	1180.06	1096.95	699.85	900.54	902.09	612.67
Tax	258.03	280.56	141.08	171.17	216.68	168.09
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	5.14	9.15	0.05	9.51	9.77	3.45
Reported Net Profit	916.89	807.24	558.72	719.86	675.64	441.13
Extraordinary Items	10.88	11.11	12.87	-0.62	2.91	-2.89
Adjusted Net Profit	906.01	796.13	545.85	720.48	672.73	444.02
Adjustment below Net Profit	-213.11	-0.92	-74.72	-68.50	-32.42	-3.85
P & L Balance brought forward	3253.44	3089.29	2694.98	2125.83	1565.51	1244.15
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	349.75	642.17	89.69	82.21	82.90	115.93
P & L Balance carried down	3607.47	3253.44	3089.29	2694.98	2125.83	1565.50
Dividend	349.75	642.17	89.69	82.21	82.90	113.44
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	1400.00	2550.00	350.00	475.00	475.00	650.00
Dividend Per Share(Rs)	28.00	51.00	7.00	9.50	9.50	13.00
Earnings Per Share-Unit Curr	73.15	63.89	44.22	83.85	77.70	50.30
Earnings Per Share(Adj)-Unit Curr	73.15	63.89	44.22	55.90	51.80	33.53
Book Value-Unit Curr	289.21	270.17	256.94	369.15	331.80	280.65
Book Value(Adj)-Unit Curr	289.21	270.17	256.94	246.10	221.20	187.10

79,273.33 753.03 ( 0.96%)

49,166.17 -297.40 (-0.60%)

7,084.21 -45.93 (-0.64%)

59,361.39 536.50 (0.91%)

10,503.87 -105.21 (-0.99%)

92.58 -0.61 (-0.65%)

108.87 -0.98 (-0.89%)

125.07 -1.17 (-0.93%)

0.58 0.00 (-0.45%)